Somatostatin receptors are often overexpressed in tumours and are potential therapeutic targets. Somatostatin receptor agonists can be used to study signaling pathways related somatostatin receptor.N-?[(1R)?-?2-?[[[3-?(Aminomethyl)?cyclohexyl]?methyl]?amino]?-?1-?(1H-?indol-?3-?ylmethyl)?-?2-?oxoethyl]?-spiro[1H-?indene-?1,?4''-?piperidine]?-?1''-?carboxamide is a selective somatostatin sst2 receptor agonist.
Potent and selective somatostatin sst 2 receptor agonist (K i values are 4, 537, 2480, 3614 and 5017 nM for cloned human sst 2 , sst 1 , sst 4 , sst 3 and sst 5 receptors respectively).